vimarsana.com
Home
Live Updates
Tiziana Expects To Start Enrolling Patients in Its Phase 2 C
Tiziana Expects To Start Enrolling Patients in Its Phase 2 C
Tiziana Expects To Start Enrolling Patients in Its Phase 2 Clinical Trial To Treat Secondary Progressive Multiple Sclerosis (SPMS) Using its Novel Intranasal…
This month, Tiziana Life Sciences TLSA expects to start enrolling patients for a phase 2a trial of Foralumab, an immunomodulation therapy for Secondary…
Related Keywords
,
Tiziana Life Sciences ,
Secondary Progressive Multiple Sclerosis ,
Have Few Effective ,
News ,
Ggregator ,
Reaking News ,
Uration ,
Media ,